Targeting HLA-DR loss in hematologic malignancies with an inhibitory chimeric antigen receptor

MLA

Liang Rong, et al. Targeting HLA-DR Loss in Hematologic Malignancies with an Inhibitory Chimeric Antigen Receptor. Nov. 2021. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....a75274fd3c1a562f942e309e3ca50383&authtype=sso&custid=ns315887.

APA

Liang Rong, Jianming Xie, Nan Jiang, Fan Fei, & Alan S. Wayne. (2021). Targeting HLA-DR loss in hematologic malignancies with an inhibitory chimeric antigen receptor.

Chicago

Liang Rong, Jianming Xie, Nan Jiang, Fan Fei, and Alan S. Wayne. 2021. “Targeting HLA-DR Loss in Hematologic Malignancies with an Inhibitory Chimeric Antigen Receptor,” November. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....a75274fd3c1a562f942e309e3ca50383&authtype=sso&custid=ns315887.